Author:
Liu Tingting,Zhou Jing,Liu Xuejiao,Xu Xiaolu
Reference33 articles.
1. Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli;Zeng;J Microbiol Immunol Infect,2023
2. Efficacy and safety of ceftazidime/avibactam: a systematic review and meta-analysis;Sternbach;J Antimicrob Chemother,2018
3. Efficacy and safety of ceftazidime-avibactam for the treatment of carbapenem- resistant Enterobacterales bloodstream infection: a systematic review and meta-analysis;Chen;Microbiol Spectr,2022
4. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
5. Population pharmacokinetics of colistin sulfate in critically ill patients: exposure and clinical efficacy;Yu;Front Pharmacol,2022